Press "Enter" to skip to content

Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal

AstraZeneca Plc and Japan’s Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan.

Original source: https://health.economictimes.indiatimes.com/news/pharma/daiichi-sankyo-astrazeneca-sign-6-9-billion-cancer-drug-deal/68624877?utm_source=RSS&utm_medium=ETRSS

Also Read:   Custom pain creams do little for chronic pain relief